Reversible Inhibitors Of Monoamine (RIMA) Antidepressants Market Trends And Growth Drivers Point To Strong Future Potential
Reversible Inhibitors Of Monoamine (RIMA) Antidepressants market size reached $5.98 billion in 2026 and is expected to grow to $7.49 billion by 2030 at a 5.8% CAGR. Major players: AbbVie Inc., Roche Holding AG, Viatris Inc.
